#Biotechnology
Latest news articles tagged with "Biotechnology". Follow the timeline of events, related topics, and entities.
Articles (30)
-
🇺🇸 Form PRE 14A PharmaCyte Biotech For: 27 February
[USA]
Related: #Securities Regulation, #Corporate Filings, #Investing
-
🇺🇸 Needham raises Personalis stock price target on reimbursement wins
[USA]
Related: #Healthcare, #Investment Analysis, #Stock Market
-
🇺🇸 Citizens raises argenx stock price target on ocular MG results
[USA]
Related: #Pharmaceutical Investment, #Market Analysis
-
🇺🇸 Form 144 ALECTOR For: 26 February
[USA]
Related: #Regulatory Filings, #Investment Activity
-
🇺🇸 Ambrose, Vertex Pharmaceuticals SVP, sells $108k in VRTX stock
[USA]
Related: #Insider Trading, #Financial Markets
-
🇺🇸 Simon, director, sells ImmunityBio (IBRX) shares worth $900k
[USA]
Related: #Insider Trading, #Financial Performance, #Market Expansion
-
🇺🇸 Generate Biomedicines prices IPO at $16 per share
[USA]
Related: #IPO, #Artificial Intelligence
-
🇺🇸 Neurogene stock surges 30% on FDA breakthrough therapy status
[USA]
Related: #Stock Market, #FDA Regulations, #Gene Therapy
-
🇺🇸 Is a Real Hair Loss Breakthrough Finally Coming?
[USA]
Smarter oral therapies and AI-designed antibody injections are on the horizon.
Related: #Medical Innovation, #Dermatology Advances -
🇺🇸 Avidity Bio earnings missed by $0.30, revenue fell short of estimates
[USA]
Related: #Earnings Reports, #Stock Performance
-
🇺🇸 Form 144 TANGO THERAPEUTICS INC For: 25 February
[USA]
Related: #Insider Trading, #Regulatory Filings
-
🇺🇸 H.C. Wainwright cuts Summit Therapeutics stock price target on China trial timing uncertainty
[USA]
Related: #Clinical Trials, #Stock Market Analysis, #Pharmaceutical Development
-
🇺🇸 Celldex completes Phase 3 enrollment for CSU treatment ahead of schedule
[USA]
Related: #Clinical Trials, #Pharmaceutical Development
-
🇺🇸 Ideaya enrolls first patient in phase 1 trial of IDE034 cancer drug
[USA]
Related: #Clinical Trials, #Cancer Treatment
- 🇺🇸 Novonesis edges lower after Q4 results, 2026 outlook trail expectations [USA] Related: #Corporate Earnings, #Market Performance
-
🇺🇸 Form 144 Krystal Biotech For: 25 February
[USA]
Related: #Insider Trading, #Market Volatility
-
🇺🇸 Form 144 Vir Biotechnology For: 25 February
[USA]
Related: #Financial Markets, #Cryptocurrency, #AI Partnerships
-
🇺🇸 Caribou Biosciences CLO sold $13,598 in CRBU stock
[USA]
Related: #Insider Trading, #Stock Market Performance
-
🇺🇸 Form 144 Protara Therapeutics For: 24 February
[USA]
Related: #Stock Market, #Regulatory Filings, #Tech Partnerships
-
🇺🇸 Caribou Biosciences CMO sells $2.1k in CRBU stock
[USA]
Related: #Insider Trading, #Stock Market Analysis
-
🇺🇸 Khan, Caribou Biosciences CBO, sells $13598 in stock
[USA]
Related: #Insider Trading, #Stock Market Performance, #Therapeutics Development
-
🇺🇸 Selecky of Immunitybio sells $250,000 in shares
[USA]
Related: #Insider Trading, #Pharmaceutical Revenue, #Market Analysis
-
🇺🇸 Simon, Barry J. sells ImmunityBio (IBRX) shares worth $1.78 million
[USA]
Related: #Insider Trading, #Stock Performance, #Partnerships
-
🇺🇸 Form 13D/A Gossamer Bio For: 24 February
[USA]
Related: #Regulatory Filings, #Market Volatility
- 🇺🇸 Daily briefing: ‘Universal’ vaccine protects mice from multiple pathogens [USA] Related: #Immunology, #Neurodegenerative Diseases, #Science Policy
-
🇺🇸 Citizens initiates Sionna Therapeutics stock at outperform, $63 target
[USA]
Related: #Pharmaceutical Development, #Stock Market Analysis
-
🇺🇸 Form 144 Twist Bioscience Corp For: 24 February
[USA]
Related: #SEC Filings, #Insider Trading
-
🇺🇸 Septerna president Bhatt sells $115,860 in shares
[USA]
Related: #Corporate Leadership, #Financial Markets, #Healthcare Innovation
-
🇺🇸 Protagonist Therapeutics director Williams sells $1.48 million in shares
[USA]
Related: #Executive Trading, #Pharmaceutical Development
-
🇺🇸 Arvinas’ (ARVN) chief medical officer Berkowitz sells $67,594 in stock
[USA]
Related: #Corporate Finance, #Regulatory Compliance